Journal article

Warfarin is not the anticoagulant of choice for malignancy-associated venous thromboembolism

Timothy D Clay, Philip Craven, Eli Gabbay

Internal Medicine Journal | WILEY | Published : 2019

DOI: 10.1111/imj.14343

University of Melbourne Researchers

Keywords

Life Sciences & Biomedicine
General & Internal Medicine
Humans
Science & Technology
Neoplasms
Pulmonary Embolism
Venous Thromboembolism
Warfarin
Medicine, General & Internal
Anticoagulants